title: [Optimization of indirect endolymphatic injection of isoniazid in pulmonary tuberculosis].
abstract: The authors have substantiated and studied the use of lymphotropic (interstitial) injection of 1% isoniazid solution in the complex therapy of patients with pulmonary tuberculosis. The method provides active interstitial functioning of the diseased organ. This leads to a substantial improvement of immediate results of treatment in patients as accelerated closure of decay cavities and double cessation of bacterial isolation.
authors.forename: I M
authors.initials: IM
authors.lastname: Peleneva
authors.forename: N A
authors.initials: NA
authors.lastname: Gariaeva
authors.forename: L V
authors.initials: LV
authors.lastname: Burukhina
authors.forename: I G
authors.initials: IG
authors.lastname: Zavgorodniĭ
authors.forename: A A
authors.initials: AA
authors.lastname: Shurygin
authors.forename: G A
authors.initials: GA
authors.lastname: Gorovits
authors.forename: I P
authors.initials: IP
authors.lastname: Miroshnikova
authors.forename: O P
authors.initials: OP
authors.lastname: Barlamov
mesh_terms: D000293:Adolescent; D000995:Antitubercular Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007272:Injections, Intralymphatic / Q000379:methods; D007538:Isoniazid / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid